Experts are increasingly focused on retatrutide, a promising medication created by Eli Lilly, as a potential breakthrough in physique reduction . Unlike many existing approaches, retatrutide is a twin-action compound targeting both GLP-1 and GIP, hormones that impact appetite and glucose balance… Read More